Daiwa Securities Group Inc. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4
-50.0%
3310.0%0.00%
Q2 2023$8
-27.3%
3310.0%0.00%
Q1 2023$11
+83.3%
3310.0%0.00%
Q4 2022$6
-99.9%
331
+34.6%
0.00%
Q3 2022$7,000
+133.3%
2460.0%0.00%
Q2 2022$3,000
-40.0%
2460.0%0.00%
Q1 2022$5,000
+25.0%
2460.0%0.00%
Q4 2021$4,000
-42.9%
2460.0%0.00%
Q3 2021$7,000
+75.0%
246
+74.5%
0.00%
Q2 2021$4,0000.0%1410.0%0.00%
Q1 2021$4,0000.0%141
+12.8%
0.00%
Q4 2020$4,000
-50.0%
125
-60.6%
0.00%
Q3 2020$8,000
+60.0%
3170.0%0.00%
Q2 2020$5,0000.0%3170.0%0.00%
Q1 2020$5,0000.0%317
+13.2%
0.00%
Q4 2019$5,000
+25.0%
2800.0%0.00%
Q3 2019$4,0000.0%2800.0%0.00%
Q2 2019$4,0000.0%2800.0%0.00%
Q1 2019$4,0000.0%280
+38.6%
0.00%
Q4 2018$4,000
-20.0%
2020.0%0.00%
Q3 2018$5,000
-16.7%
2020.0%0.00%
Q2 2018$6,0000.0%2020.0%0.00%
Q1 2018$6,0002020.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders